Jefferies Assumes Infosys Technologies (INFY) at Buy
- Market Wrap: Pending Sales Slide in June; Herbalife Hit on Q2 Results, Outlook; Netflix...Yada, Yada, Yada...Seinfeld?
- After-Hours Stock Movers 7/28: (CGNX) (HLS) (AMKR) Higher; (KBIO) (HLF) (TTS) Lower (more...)
- Herbalife (HLF) Misses Q2 EPS by 2c; Guides Q3 EPS Below Views
- Dollar Tree (DLTR) to Acquire Family Dollar (FDO) for $74.50/Share
- Darden Restaurants (DRI) Chairman, CEO Otis to Step Down
Jefferies assumes coverage on Infosys Technologies (NYSE: INFY) with a Buy rating and a price target of $60.00 (from $66.00).
Analyst Atul Goyal notes, "Infosys’ consulting focus approach is evident from the fact that it contributes to a third of its revenues with 44% of revenues from ADM and testing. The company also remains amongst the most leveraged to the US economy, deriving 60% of its revenues from the region with 25% from Europe. On its main business differentiator, he adds, "Infosys is recognized as one of the best delivery organizations, and it commands a 10-15% pricing premium over peers. Its exposure to consulting also makes it the most leveraged to a pickup in discretionary spending."
Commenting on key drivers for the stock price, the analyst highlights: "Infosys is at a stage where most financial metrics are at their worst. Growth has been volatile; margins have fallen 450bps (in the last 13 quarters) despite a currency tailwind. We believe that given the recent reset of expectations for next year, an improvement in either growth or margins would be perceived a positive. Turnaround hopes are hinged on Chairman Murthy."
Shares of Infosys Technologies closed at $52.55 yesterday.
You May Also Be Interested In
- UPDATE: BMO Capital Downgrades Pfizer (PFE) to Market Perform
- Deutsche Bank Downgrades Enphase Energy (ENPH) to Hold
- Silicon Labs (SLAB) PT, Estimates Trimmed at Needham & Company; 'Buy' Maintained
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst PT Change, New Coverage
Related EntitiesJefferies & Co
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!